Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BFRIthis companyBiofrontera Inc.	$0.84	-0.55×	0.55×	0.14×	-0.61×	-3679.1%	78.7%	-21.9%	-25.3%	-100.5%	-53.8%	-230.5%	0.59×	0.03×	-20.24×	1.52×	0.0%	2	-6.17	1	C-
AYTUAytu BioPharma, Inc.	$1.86	-1.85×	0.75×	0.46×	-4.17×	-322.8%	64.0%	-14.4%	-24.8%	-40.4%	-14.2%	12.3%	0.51×	1.87×	4.39×	1.13×	0.0%	4	-4.22	2	C
COCPCocrystal Pharma, Inc.	$1.05	-1.26×	1.75×	0×	-0.65×	-55.3%	0.0%	0.0%	0.0%	-139.5%	-115.1%	-74.2%	0.24×	0.65×	0×	3.68×	0.0%	3	-108.13	1	C-
DWTXDogwood Therapeutics, Inc.	$1.17	-0.96×	0.46×	0×	-0.82×	-43.2%	0.0%	0.0%	0.0%	-45.7%	-32.1%	-45.7%	0×	0.19×	0×	2.76×	0.0%	1	-1.2	3	B
IMNNImunon, Inc.	$0.91	-0.56×	1.15×	0×	-0.02×	252.7%	0.0%	0.0%	0.0%	-205.3%	-181.5%	-175.3%	0.14×	0.56×	0×	2.32×	0.1%	1	-42.64	2	C+
SBFMSunshine Biopharma, Inc.	$2.71	-0.85×	0.22×	0.14×	0.57×	-12667986.8%	32.8%	-12.3%	-16.5%	-25.9%	-18.8%	-107.7%	0.04×	1.48×	0×	4.17×	0.0%	2	-1.27	3	B-
Peer median	—	-0.96×	0.75×	0×	-0.65×	-55.3%	0.0%	0.0%	0.0%	-45.7%	-32.1%	-74.2%	0.14×	0.65×	0×	2.76×	0.0%	2	-4.22	2	—